
WSJ: Pfizer considering $5 billion takeover of GBT
Pfizer has been looking for assets in the biopharmaceutical space to expand its pipeline thanks to the big money it has made from COVID-19. Now,
Pfizer has been looking for assets in the biopharmaceutical space to expand its pipeline thanks to the big money it has made from COVID-19. Now,